Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B

Pharmaceutical Research

Volumn 18, Issue 3, 2001, Pages 344-351

  Moreno, Marco Antonio ^a   Frutos, Paloma ^a   Ballesteros, Ma Paloma ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Amphotericin B; Lecithin based oil water microemulsions; Lyophilization; Single dose acute toxicity; Stability

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; MYRISTIC ACID ISOPROPYL ESTER; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; WATER; WATER OIL CREAM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; FLOW KINETICS; FREEZE DRYING; IN VIVO STUDY; INTERCALATION COMPLEX; LD 50; MALE; MICROEMULSION; MOUSE; NONHUMAN; PARTICLE SIZE; PARTITION COEFFICIENT; PRIORITY JOURNAL; ULTRAVIOLET SPECTROPHOTOMETRY;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CHEMISTRY, PHYSICAL; EMULSIONS; EXCIPIENTS; FREEZE DRYING; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; RHEOLOGY; SPECTROPHOTOMETRY, ULTRAVIOLET; VISCOSITY;

EID: 0034961459     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011011215418     Document Type: Article

References (27)

1. Amphotericin B: Current understanding of mechanisms of action
2. Infection in bone marrow transplants recipients
3. Disseminated fusarial infection in the immunocompromised host
4. Pharmacokinetics and toxicity of continuous infusion of amphotericin B cancer patients
5. Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes
6. Nephrotoxicity of amphotericin B
7. The use of amphotericin B in nosocomial fungal infection
8. Clinical use of amphotericin B and derivatives: Lore, mystique and fact
9. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis
10. Emulsion de Iamphotéricine B dans IIntralipide® 20%: Efficacité in vitro et in vivo
11. Stability of an amphotericin B emulsion formulation
12. New techniques for preparing submicronic emulsions: Application to amphotericin B
13. Treatment and prophylaxix of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B
14. Liposome-encapsulated amphotericin B for the treatment of disseminated candidiases in neutropenic mice
15. Liposomes as carriers of antimicrobial agents
16. Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment candidiasis in mice
17. Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B
18. Complexes of amphotericin B and cholesteryl sulfate
19. Amphotericin B lipid complex (ABCL): A molecular rationale for the attenuation of amphotericin B related toxicities
20. Extraction and liquid chromatographic determination of amphotericin B in oil-water lecthin-based microemulsions
21. Hydrolysis of partially saturated egg phosphatidilcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics
22. Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B lipid state and cholesterol content dependence
23. Effect of aggregation and solvent on the activity of amphotericin B on human erythrocytes
24. Surfactant systems: Microemulsions and vesicles as vehicles for drug delivery